ALK-positive Non-small-cell Lung Cancer

Explore clinical trials studying ALK-positive Non-small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

ALK-positive Non-small-cell Lung Cancer trial results

Completed

NCT04979988

Conditions: ALK-positive Non-small-cell Lung Cancer
Locations: Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan

Fujita Health University Hospital Toyoake, Aichi-ken, Japan

Kanagawa Cancer Center Yokohama, Kanagawa, Japan

Kurashiki Central Hospital Kurashiki, Okayama-ken, Japan

View all 16 locations

Active, Not Recruiting

NCT07567352

Conditions: ALK-positive Advanced NSCLC, ALK-positive NSCLC, ALK-positive Non-small-cell Lung Cancer, +11 more
Locations: Pfizer New York, United States